Completed × Central Nervous System Neoplasms × Sarcoma × Clear all Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
Phase 2 Completed
35 enrolled 13 charts
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Phase 1/2 Completed
116 enrolled 31 charts
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
20 enrolled 12 charts
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
18 enrolled 12 charts
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
4 enrolled 12 charts
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
6 enrolled 12 charts
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
AcSé
Phase 2 Completed
334 enrolled
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Phase NA Completed
44 enrolled
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Phase 1/2 Completed
76 enrolled 25 charts
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Phase 1/2 Completed
64 enrolled 29 charts
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 3 Completed
562 enrolled 11 charts
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2 Completed
45 enrolled
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
36 enrolled
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Phase 2 Completed
118 enrolled 8 charts
MSC11FCD-GBM
Phase 1/2 Completed
10 enrolled
RTOG 0913
Phase 1/2 Completed
279 enrolled 14 charts
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Phase 2 Completed
178 enrolled 23 charts
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
Phase 2 Completed
73 enrolled
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
Phase 2 Completed
68 enrolled
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Completed
18 enrolled
Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
Phase 2 Completed
80 enrolled
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2 Completed
77 enrolled
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2 Completed
70 enrolled 18 charts
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2 Completed
24 enrolled 10 charts
Sirolimus in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
13 enrolled
Vaccine Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
28 enrolled
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
19 enrolled
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Completed
76 enrolled
SarCNU in Treating Patients With Recurrent Malignant Glioma
Phase 2 Completed
10 enrolled
DEND/TIA
Phase 1/2 Completed
6 enrolled
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1/2 Completed
122 enrolled 11 charts
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
217 enrolled 12 charts
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
Phase 2 Completed
55 enrolled 10 charts
Study of Blood and Cheek Cell Samples From Patients With Glioma
Completed
1,709 enrolled
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
92 enrolled 18 charts
Gene Therapy in Treating Patients With Primary Brain Tumors
Phase 1 Completed
Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1/2 Completed
35 enrolled 13 charts
TAVAREC
Phase 2 Completed
155 enrolled
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
Phase NA Completed
12 enrolled
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Completed
631 enrolled
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Phase 2 Completed
25 enrolled 10 charts
Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2 Completed
115 enrolled 11 charts
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Phase 1 Completed
3 enrolled
O(6)-Benzylguanine in Treating Patients With Malignant Glioma
Phase 1 Completed
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
Phase 2 Completed
82 enrolled
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Phase 1 Completed